Trending...
- Eric Friend Releases Inspiring Memoir "Through It: A Journey of Strength, Resilience, and Purpose
- 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
- California: Governor Newsom expands statewide partnerships with additional cities to clean up encampments on highways
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to virtually participate in the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021, at 11:00 a.m. PST.
A live and archived webcast for this event will be available in the Investors section of the Glaukos website at http://investors.glaukos.com.
About Glaukos
Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent®, its first MIGS device, in the United States in July 2012, its next-generation iStent inject® device in the United States in September 2018 and most recently, its iStent injectW device in the United States in October 2020. In corneal health, Glaukos' proprietary suite of single-use, bio-activated pharmaceuticals are designed to strengthen, stabilize and reshape the cornea through a process called corneal collagen cross-linking to treat corneal ectatic disorders and correct refractive conditions. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease.
More on The Californer
A live and archived webcast for this event will be available in the Investors section of the Glaukos website at http://investors.glaukos.com.
About Glaukos
Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent®, its first MIGS device, in the United States in July 2012, its next-generation iStent inject® device in the United States in September 2018 and most recently, its iStent injectW device in the United States in October 2020. In corneal health, Glaukos' proprietary suite of single-use, bio-activated pharmaceuticals are designed to strengthen, stabilize and reshape the cornea through a process called corneal collagen cross-linking to treat corneal ectatic disorders and correct refractive conditions. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease.
More on The Californer
- Synergize Inc. Team Attends National Leadership Conference in Dallas
- United Debt Relief: Price the Cost of Staying in Debt, Not Just the Program
- Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments
- Alex Hormozi referenced Eugene Schwartz when he was helping an entrepreneur scale their business
- Extreme Heat, Shark Sightings, and a Warning From the Ocean
Filed Under: Business
0 Comments
Latest on The Californer
- Making Waves for World Drowning Prevention Day in San Dimas
- Oakdale Community Pool Day Hosted by Swim Up Hill Foundation
- Brittany Poliska Launches Wellness Passport at Temecula Valley Event
- Anamorphic 3D Only Works on Fixed Screens. Loud! OOH Put It on a Moving Ad Van for Flood Re
- From DJ Booths to Disney: Orlando Author Ryan Tiffin Launches "Chasing Magic"
- FDA Food Recall Notices After Outbreak Linked to 98 Hospitalizations: Practical Tips for Safer Grocery Shopping
- The 'Tax Squeeze': Betsson's Record Quarter Previews the Economics of Finland's 2027 Casino Market
- Nationwide Boiler Announces Leadership Succession, Appoints Jim Lieskovan as President
- California launches next phase of state cybersecurity plan as AI changes threat landscape
- California se moviliza para proteger a las comunidades mientras el calor del verano afecta al oeste del país
- California mobilizes to protect communities as summer heat builds across the West
- Pathways of Hope was awarded the highest level of accreditation with Pulse For Good
- Marcus Christ To Release Five Singles From The American Pharaoh Double Album
- Governor Newsom announces California will raise statewide minimum wage
- Backtested Strategies Announces BTS Zones — Industry Sectors Backtest Results
- ImagineX Acquires Payteros to Strengthen Digital Transformation Capabilities
- The Clean‑Energy Breakthrough Poised to Transform Global Power Stability
- From Pizza to Playlists: Marty The Pizza Guy Delivers Three Delicious New Songs
- Allison Murray Rejoins Snell & Wilmer's Orange County Office
- Snell & Wilmer Welcomes Associate Eman F. Ateyeh to the Orange County Office